WitrynaAnticancer Research, In Vivo, Cancer Genomics & Proteomics, and Cancer Diagnosis & Prognosis are independent international journals, published by the International … Witryna1 dzień temu · Aims and scope. Journal metrics Editorial board. Expert Review of Anticancer Therapy [ISSN 1473-7140]; [e-ISSN 1744-8328] is a MEDLINE-indexed, international journal publishing comprehensive peer-reviewed content on the major issues in clinical oncology. Coverage in the journal is focused on, but not limited to, …
Anticancer Research - Impact Factor & Score 2024 Research.com
Witryna1 kwi 2024 · Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic … Witryna11 kwi 2024 · The "Journal of Cancer Research and Clinical Oncology" (formerly Zeitschrift für Krebsforschung, founded in 1904) contains significant and up-to-date articles within the fields of experimental, translational and clinical oncology. ... Impact factor 4.176 (2024) Five year impact factor 4 days Submission to first decision … how to stream 17 again
Anticancer Research Impact Factor IF 2024 2024 2024 - BioxBio
Anticancer Research is an independent international peer-reviewed medical journal published by the International Institute of Anticancer Research, addressing experimental and clinical topics in oncology. Issues are released monthly print and online (by Highwire Press), and an annual Index is also published. Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2024 impact factor of 2.480 and 25,6… WitrynaImpact Factor Cancer Discovery: 38.272 Cancer Epidemiology, Biomarkers & Prevention: 4.090 Cancer Immunology Research: 12.020 Cancer Prevention Research: 3.296 Cancer Research: 13.312 Clinical Cancer Research: 13.801 Molecular Cancer Research: 6.333 Molecular Cancer Therapeutics: 6.009 Witryna6 kwi 2024 · The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs. Specific areas of focus ... readiness level 3